Canadian Cardiovascular Society

Hypertrophic Cardiomyopathy Learning Series 2.0

Welcome to the CCS Hypertrophic Cardiomyopathy Learning Series 2.0, launched in 2023 as a continuation of the original six-part series which was held in 2022. This educational series is designed to support learning and to refine the knowledge and skills of specialists and primary care providers on topics related to Hypertrophic Cardiomyopathy.

Program Chairs:

Dr. Michael Chetrit
Dr. Anil Gupta
Dr. Gillian Nesbitt

Past Events:

Session 1: Expressions in HCM: Strategies to Develop a Differential Diagnosis and the Value of Initial Testing
Date: April 26, 2023 from 8:00 p.m. to 9:00 p.m. EDT
Faculty: Dr. Natalie Ho, Dr. Emily Lai, and Dr. Kevin Ong


Session 2: Unraveling the Puzzle – A Comprehensive Approach to Initial Management of
Symptomatic HCM

Date: September 27, 2023 from 8:00 p.m. to 9:00 p.m. EDT 
Faculty: Dr. Tara Sedlak, Dr. Francois Tournoux, and Dr. Amer Johri 


Session 3: From Guidelines to Breakthroughs – Optimizing Treatment Options for Patients with HCM
Date: October 28, 2023 from 12:30 p.m. to 1:30 p.m. ET 
Location: Vascular 2023 at Palais des congrès de Montréal
Faculty: Dr. Kim Anderson, Dr. Michael Ward, and Dr. Patrick Garceau


This session has received an educational grant from Bristol Myers Squibb Canada. This program was developed by the Canadian Cardiovascular Society and was planned to achieve scientific integrity, objectivity, and balance.

 

Back to top